Welcome to PsychU!

Depression

Major depressive disorder affects millions of Americans, causing high costs in both human suffering and medical expenditures. Here in this library you will find hundreds of helpful resources to help in diagnosis and treatment.

Featured Resources

Managing Partial Response: Augmentation Strategies In MDD

Managing Partial Response: Augmentation Strategies In MDD

Persistent residual symptoms (e.g., sleep disturbances, cognitive symptoms) have known interference on quality of life and functioning of individuals with major depressive disorder (MDD) who respond to or remit from antidepressant treatment.1 Understanding the inherent challenges in symptom recognition and subsequent treatment, clinicians are tasked with finding optimal symptom relief…
26% More U.S. Children Experienced Anxiety Or Depression During First Year Of COVID-19

26% More U.S. Children Experienced Anxiety Or Depression During First Year Of COVID-19

About 26% more children in the United States experienced anxiety or depression during the first year of the coronavirus disease 2019 (COVID-19) public health emergency, according to a report from the Annie E. Casey Foundation (AECF). Prior to COVID-19 (in 2016), about 9.4% of children ages 3 through 17 (5.8…

Upcoming Events

Section Advisors

  • Christine Yu Moutier, MD

    Major Depressive Disorder Section Advisor

  • Gaurava Agarwal, MD

    Speakers

Ask A Question About Depression

Enter your question in the box below and click “Ask My Question” to submit your inquiry.

You must be logged in to ask a question in this section.

Disclaimer: The information provided by PsychU is intended for your educational benefit only. It is not intended as, nor is it a substitute for medical care or advice or professional diagnosis. Treatment-related questions will not be addressed. Users seeking medical advice should consult with their physician or other healthcare professional.

Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) operates in a highly regulated and scrutinized industry. Therefore, we may not be able to address every questions or topic submitted. Topics which may not be addressed may include, but are not limited to questions related to: (1) specific medications, (2) branded items, (3) clinical or treatment advice relating to specific patient conditions. The lack of response to certain questions or comments should not be taken as an agreement with the view posed or an admission of any kind.

REQUEST A PRESENTATION

Request a free educational program for your organization or region today! These customizable PsychU presentations are available both online and in-person, and cover a range of topics including: schizophrenia, major depressive disorder, bipolar disorder, care coordination, quality standards, and more.

Top Requested Presentations

The Neuropsychiatric Inventory: Development & Applications

Diagnostic & Statistical Manual Of Mental Disorders–Fifth Edition (DSM-5): Key Updates VS DSM-IV-TR

Distinguishing Sedation From Efficacy In Antipsychotic Treatment

Learning Tracks